
Significant insider selling has been a strong bearish indicator since 2021, often preceding stock underperformance for the next 1 to 12 months. A current example is Hims & Hers Health (HIMS), which could face pressure due to a large CEO sale combined with slowing business growth. Conversely, insider buying is most effective when it aligns with a positive trend for the entire sector. For instance, insider buying at Tilray Brands (TLRY) preceded a major rally, supported by a bullish outlook for the cannabis industry. This same strategy proved successful for Kratos Defense & Security Solutions (KTOS), where CEO buying combined with a favorable view of the defense industry led to strong gains.
The core investment strategy discussed is based on analyzing the trading activity of company insiders (like CEOs and executives).
• Insider Selling is a Stronger Signal: The speaker argues that, since at least 2021, insider selling has been a more reliable indicator than insider buying. - When insiders sell, the stock tends to underperform the market over the next 1 to 12 months. - This negative signal appears to get stronger over time (i.e., the underperformance is worse at 6 or 12 months than at 1 month).
• Insider Buying is a Weaker Signal: When insiders buy, the stock does not consistently outperform the market. - Any positive signal from insider buying is typically very short-term, concentrated in the 1 week to 1 month period after the purchase.
• Pay close attention to insider selling. A notable sale by a key executive in a stock you own could be a signal to consider selling. If you are considering buying a stock, significant insider selling could be a reason to avoid it. • Be selective with insider buying signals. Only act on insider buying when it aligns with a separate, strong, bullish story for the company's industry or sector. The podcast provides examples of combining insider buying with favorable political or regulatory trends.
• Insiders were reportedly "dumping the stock" around the June timeframe. • The speaker viewed this as a strong sell signal and sold their position. • The stock price is described as being "way down since then."
• The significant insider selling at GitLab in June was presented as a successful bearish (negative) indicator that preceded a drop in the stock's price.
• The ex-CEO of Snowflake made his largest-ever sales of the stock around the June timeframe. • This was highlighted as a major red flag, prompting the speaker to sell their shares. • The stock is noted to be "way down since then."
• A record-breaking sale by a former top executive was a powerful signal to sell Snowflake stock, according to the speaker's strategy.
• CEO Brian Armstrong made sales described as "million and million sales," which were his largest sales ever. • These sales occurred around the June timeframe. • Following these sales, the stock price is said to be "way down."
• The CEO's largest-ever stock sale was a significant bearish event for Coinbase, preceding a price decline. This reinforces the strategy of treating large insider sales as a potential warning sign.
• The speaker was already bullish on the defense industry as a whole, believing it would benefit from the political environment ("Trump has been very pro the defense industry"). • In the spring, the CEO of Kratos was observed buying the stock. • This combination of a bullish sector view and a bullish insider action gave the speaker confidence to invest. • KTOS was added to the speaker's portfolio and became the best-performing stock in their basket of defense plays.
• This is presented as a model for a successful investment based on insider buying. • The key was the alignment of two signals: a positive outlook for the entire sector (defense) and a specific positive action within that sector (the KTOS CEO buying shares).
• The speaker identified a bullish theme for the cannabis sector, based on the idea that "Trump has appeared to be pretty pro-cannabis and likely to reclassify it." • Insiders at Tilray were seen buying stock at the end of July and beginning of August. • The stock was already up over 50% since those insider purchases.
• This is another example of successfully combining a broad industry catalyst (potential cannabis reclassification) with a specific company signal (insider buying at Tilray). • The alignment of these two factors preceded a significant and rapid increase in the stock price.
• This company was presented as a current, actionable idea based on negative signals. • The company has faced negative press and reported "iffy" earnings with slowing growth. • On top of these fundamental issues, the CEO made a massive sale of the stock.
• HIMS is presented as a bearish (negative) idea. • The case against the stock is built on a combination of weakening business fundamentals (slowing growth, bad press) and a strong insider sell signal (large CEO sale). This alignment of negative factors suggests potential for the stock to underperform.